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Dendritic cells efﬁciently internalize exogenous protein
antigens by ﬂuid-phase uptake and receptor-mediated
endocytosis. Such antigens contribute to cross-presenta-
tion by being translocated into the cytosol for proteasomal
degradation, which liberates immunogenic peptides that
can bind to major histocompatibility complex (MHC) class
I molecules after being transported into the endoplasmic
reticulum (ER). MHC class I–peptide complexes are then
expressed on the cell surface and presented to CD8
þ
T cells. Here we show that internalized proteins can have
an alternative fate. After internalization, proteins are ﬁrst
unfolded to allow translocation into the cytosol using a
pathway related to ER-associated degradation (ERAD).
Subsequently the unfolded proteins can undergo cytosolic
refolding assisted by the chaperone Hsp90. These observa-
tions not only clarify the cellular processes regulating
cytosolic access following endocytosis, but also demon-
strate that functional proteins can potentially regain their
activity in the cytosol of dendritic cells.
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Introduction
Major histocompatibility complex (MHC) class I molecules
were initially believed to present peptides derived solely from
endogenous proteins, that is, proteins synthesized by the cell
itself, including viral proteins produced upon infection.
Subsequently, it was discovered that exogenous antigens
could be presented by MHC class I molecules and stimulate
CD8
þ Tcells. This process is called cross-presentation and is
critical for the initiation of T-cell immunity to viral infections
(Rock and Shen, 2005). Dendritic cells (DCs) are the major
cell types that mediate cross-presentation, and they can
generate functional MHC class I–peptide complexes from
exogenous proteins internalized via various endocytic me-
chanisms such as phagocytosis, macropinocytosis, or recep-
tor-mediated endocytosis. They can cross-present exogenous
antigens in the form of soluble proteins, immune complexes,
or apoptotic bodies derived from virally infected cells
(Rodriguez et al, 1999; Mellman and Steinman, 2001).
We previously showed that efﬁcient internalization of
exogenous antigens by DCs is followed by their translocation
into the cytosol via an endoplasmic reticulum (ER)-asso-
ciated degradation (ERAD)-related mechanism (Ackerman
et al, 2006; Rock, 2006). In the ERAD pathway, misfolded
or unassembled proteins in the ER are targeted for degrada-
tion through the cytoplasmic ubiquitin–proteasome system
(Meusser et al, 2005). Misfolded substrates are ﬁrst selected
and recognized by lumenal chaperones (e.g., BiP, GRP94) and
then targeted for dislocation into the cytosol (retrotrans-
location; Matlack et al, 1999; Nishikawa et al, 2005).
Retrotranslocation probably uses the Sec61 channel or a
related channel involving Derlin-1, and it is coordinated by
the Cdc48p–Npl4p–Ufd1p complex, which constitutes a
transport cascade for substrate delivery from the site of
ubiquitination to the proteasome (Ye et al, 2001, 2003;
Lilley and Ploegh, 2004; Wahlman et al, 2007). Whether
derived from ER proteins or from exogenous proteins inter-
nalized by DCs, peptides generated by the proteasome
may then be translocated into the ER by the transporter asso-
ciated with antigen processing (TAP) and loaded onto MHC
class I molecules using the classical TAP-dependent MHC
class I assembly pathway (Cresswell et al, 2005). MHC
class I–peptide complexes are then transported via the Golgi
apparatus to the cell surface and surveyed by CD8
þ Tce ll s .
Here we show that in DCs, in addition to dislocation
followed by immunogenic peptide generation, exogenous
proteins can use the same mechanism for cytosolic access
and be refolded in the cytosol rather than being degraded. At
least partial unfolding appears to precede retrotranslocation.
It has previously been proposed that cytosolic chaperones
such as Hsp90 cooperate with the ERAD pathway to deter-
mine the fate of misfolded proteins (Wang et al, 2006), and
here we show a similar requirement for the functional
refolding of exogenous proteins in the cytosol of DCs.
Results
Exogenous proteins access the cytosol of the DC-like
cell line KG-1 in a folded and functional form
To investigate the kinetics of internalization of exogenous
soluble proteins and their entry into the cytosol, we designed
a new set of assays using soluble recombinant Fireﬂy and
Renilla reniformis luciferases as substrates. From previous
studies we know that soluble luciferases are efﬁciently inter-
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201nalized by ﬂuid-phase uptake by the DC-like cell line
KG-1 (Ackerman et al, 2006). To measure exogenous protein
delivery to the cytosol, KG-1 cells that had internalized
soluble luciferases were permeabilized with streptolysin-O
(SLO). SLO permeabilization allowed the measurement of
cytosolic luciferase activity in the supernatants of the cells
following centrifugation. We established that in KG-1 cells
luciferase activity was present in the cytosol after 5min of
internalization. No luciferase activity could be detected in the
cytosol of CEM cells, a human T lymphoblastoid cell line with
poor macropinocytotic capacity (Figure 1A and B). To ensure
that the SLO permeabilization procedure was speciﬁcally
releasing cytosolic components without ER or lysosomal
leakage, supernatants from untreated or SLO-treated cells
were subjected to SDS–PAGE and immunoblotted for p44/
42 MAP kinase (MAPK) as a cytosolic marker, GRP94 as an
ER marker, and gamma-interferon-inducible lysosomal thiol-
reductase (GILT; Arunachalam et al, 2000) as a lysosomal
marker. Figure 1C clearly shows that supernatants from SLO-
permeabilized cells contained the cytosolic marker p42/44
MAPK, whereas GRP94 and GILT were undetectable. We
also showed that endosomal integrity was maintained
upon SLO permeabilization: a 10-kDa ﬂuorescein-conjugated
Dextran internalized by KG-1 cells was undetectable in
supernatants from SLO-treated cells, but was readily detect-
able in the residual cell pellet following permeabilization
(Supplementary Figure 1).
Cytosolic access is inhibited by cytochalasin D
pretreatment
We wanted to ensure that the luciferase activity present in the
cytosol of KG-1 cells was dependent on active internalization.
Macropinocytosis, the predominant mechanism of ﬂuid-
phase uptake by DCs, is an actin-dependent process
(Sallusto et al, 1995; Amyere et al, 2002). KG-1 cells were
therefore pretreated with the actin polymerization inhibitor
cytochalasin D for 30min before addition of luciferase for an
additional 30min. Exposure to cytochalasin D strongly re-
duced the luciferase activity liberated into the supernatants of
SLO-permeabilized cells (Figure 2A, black bar) compared
with control cells treated with vehicle (DMSO) alone
(Figure 2A, light gray bar). No signiﬁcant luciferase activity
was detected in the supernatants of non-permeabilized cells
(Figure 2A, white and dark gray bars). Cytochalasin D treat-
ment also decreased signiﬁcantly the total amount of Fireﬂy
luciferase internalized by KG-1 cells, as assessed by enzy-
matic activity measured after detergent lysis (Supplementary
Figure 2). These data indicate that internalization of exogen-
ous luciferase is actin-dependent. We interpret this to suggest
that luciferase is internalized by macropinocytosis followed
by its translocation into the cytosol of KG-1 cells.
Access of luciferase to the cytosol is inhibited by
Exotoxin A
To investigate the mechanism by which exogenous luciferase
enters the cytosol of KG-1 cells, we used Exotoxin A (ExoA), a
bacterial toxin derived from Pseudomonas aeruginosa.E x o A
reversibly inhibits retrotranslocation from the ER into the
cytosol, a process putatively mediated by the Sec61 channel
(Koopmann et al, 2000). We have recently shown that ExoA
is efﬁciently internalized by KG-1 cells expressing the mouse
MHC class I allele H2-K
b, and that it can block cross-
presentation of the soluble antigen ovalbumin (OVA) to a
K
b-restricted T-cell hybridoma (Ackerman et al, 2006). This
ﬁnding was used in part to argue that ERAD-like mechanisms
govern cross-presentation. To determine if luciferase accesses
the cytosol using the same ExoA-inhibitable pathway, we
mixed soluble ExoA, or BSA as a control, at increasing
concentrations with a ﬁxed concentration of Fireﬂy luciferase
and added them to KG-1 cells. The addition of ExoA signiﬁ-
cantly reduced the luciferase activity detectable in super-
natants of SLO-permeabilized cells (Figure 2B, solid lines)
compared with the BSA control (Figure 2B, dashed lines). No
signiﬁcant luciferase activity was detected in the supernatant
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Figure 1 Exogenous luciferase enters the cytosol of KG-1 cells
following internalization. (A, B) Fireﬂy luciferase (A) or R. renifor-
mis luciferase (B) were added to KG-1 cells (K) or CEM cells ( and
&) for the indicated times. Cells were then permeabilized with SLO
in the presence of DTT (þ SLO, solid lines) or resuspended in DPBS
with DTT (  SLO, dashed lines) as controls. After centrifugation,
supernatants from SLO-permeabilized cells or control cells were
analyzed for luciferase activity with a luminometer. All graphs
show the mean value (7s.d.) of triplicate samples and they are
representative of at least three independent experiments. (C)T o
ensure speciﬁc cytosolic isolation from SLO-permeabilized cells,
supernatants from KG-1 cells (left panel) or CEM cells (right panel)
treated with or without SLO were analyzed by western blotting for
the ER lumenal marker GRP94, the cytosolic marker p44/42 MAPK,
and the lysosomal marker GILT.
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effect was clearly dose-dependent, with reduced luciferase
activity present at higher concentrations of ExoA. ExoA did
not affect luciferase uptake or the capacity of the cytosol to
mediate refolding (Supplementary Figure 3). These data
strongly suggest that luciferase is dislocated into the cytosol
by the same mechanism used by exogenous antigens during
cross-presentation by DCs.
Fireﬂy and Renilla luciferases can refold in vitro
The assay we have developed is based on the ability to detect
luciferase activity in cytosolic fractions derived from KG-1
cells. This implies that both Fireﬂy and Renilla luciferases can
access the cytosol in a folded and functionally active form. To
investigate whether the luciferase activity detected in super-
natants of SLO-permeabilized cells might depend on cytosolic
refolding, we performed preliminary in vitro refolding experi-
ments. Fireﬂy or Renilla luciferases were chemically unfolded
in 6M guanidine–HCl in intracellular transport (ICT) buffer
for 30min at room temperature. This procedure completely
abrogated the activities of both enzymes (Figure 3A and B,
white circles). To determine if cytosolic components could
mediate refolding, unfolded luciferases were added to serial
dilutions of cytosol isolated from KG-1 cells that was dialyzed
into ICT buffer. Both Fireﬂy and Renilla luciferases were
efﬁciently refolded in vitro after 30min incubation at room
temperature in the presence of KG-1 cytosol (Figure 3A and B,
black triangles). No signiﬁcant refolding was observed in
the presence of ICT buffer alone (Figure 3A and B, black
squares). Cytosol similarly isolated from CEM cells was also
capable of refolding luciferases in vitro, indicating that no
speciﬁc property of KG-1 cytosol was responsible (data not
shown). Extending refolding reactions up to 1h and adding
protease inhibitors or lactacystin to the refolding reactions
did not increase refolding efﬁciency signiﬁcantly (data not
shown). Taken together, these data suggest that after being
internalized and retrotranslocated into the cytosol, Fireﬂy
and Renilla luciferases could potentially undergo refolding
in the DC-like cell line KG-1.
Hsp90 in the cytosol seemed a likely candidate for mediat-
ing the in vitro luciferase refolding. We therefore examined
the effect of the potent Hsp90 inhibitor radicicol (Schulte
et al, 1998; Sharma et al, 1998) on the refolding reaction.
After chemical unfolding, we observed a dose-dependent
inhibition of Fireﬂy luciferase refolding by radicicol in the
presence of KG-1 cytosol (Figure 3C, gray bars). No inhibition
occurred in cytosol containing DMSO as control (Figure 3C,
white bars), and no signiﬁcant refolding was observed in 6M
guanidine–HCl or in ICT buffer alone (Figure 3C, ﬁrst three
columns). These data suggest that in vitro luciferase refolding
is mediated by the cytosolic chaperone Hsp90.
Exogenous Fireﬂy and Renilla luciferases are refolded
in the cytosol by Hsp90
We wished to determine if the recovery of active luciferase
from the cytosol of KG-1 cells depended upon refolding. For
this purpose, Renilla luciferase was denatured in 6M guani-
dine–HCl in ICT buffer and dialyzed overnight against PBS.
After dialysis against PBS, chemically unfolded Renilla
luciferase, but not Fireﬂy luciferase, remained soluble but
enzymatically inactive (Supplementary Figure 4). However,
when the inactive enzyme was added to KG-1 cells, we could
detect signiﬁcant luciferase activity in the cytosol released by
SLO permeabilization (Figure 4A, solid black lines). The
activity recovered after addition of 20mg of unfolded Renilla
luciferase was comparable to that recovered after adding
0.2mg of native enzyme to the same number of KG-1 cells
(Figure 4A, solid gray lines). No signiﬁcant luciferase activity
was detected in the supernatants from non-permeabilized
cells incubated with either folded enzyme (Figure 4A, gray
square symbols with dashed lines) or unfolded enzyme
(Figure 4A, black circles with dashed lines), and no sponta-
neous refolding was observed in the cell culture medium
(data not shown). These data strongly favor the hypothesis
that cytosolic refolding occurs after internalization by
KG-1 cells.
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Figure 2 Cytosolic access is inhibited by cytochalasin D and by
Pseudomonas ExoA. (A) KG-1 cells, pretreated for 30min with
cytochalasin D (10mg/ml), added in DMSO (Cyto D, and &)o r
with DMSO added as control (Ctr, and ), were incubated with
Fireﬂy luciferase for 30min. Cells were then permeabilized with
SLO in the presence of DTT (þ SLO, and &) or resuspended in
DPBS with DTT (  SLO, and ) as a control. After centrifuga-
tion, supernatants were analyzed for luciferase activity. The values
are presented as percentages of those obtained with DMSO alone.
(B) ExoA (solid lines) or BSA (dashed lines) was added at the
indicated concentrations together with Fireﬂy luciferase for 15min
at 371C to allow co-internalization. Cells were then permeabilized
with SLO in the presence of DTT (þ SLO, K) or resuspended in
DPBS with DTT (  SLO, m). After centrifugation, supernatants from
SLO-permeabilized cells or control cells were analyzed for luciferase
activity. All graphs show the mean value (7s.d.) of triplicate
samples and the results are representative of at least three inde-
pendent experiments.
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was the critical chaperone. To determine whether this was the
case for in vivo refolding, we again used the Hsp90 inhibitor,
radicicol. KG-1 cells were pretreated with radicicol for 1h
before 15-min incubation with native Fireﬂy or unfolded
Renilla luciferase, followed by washing and SLO permeabili-
zation. Radicicol pretreatment strongly reduced the cytosolic
activity recovered for both enzymes (Figure 4B and C, gray
bars). No signiﬁcant luciferase activity was detected in super-
natants of non-permeabilized cells (Figure 4B and C, white
bars). Similar results were obtained with overnight radicicol
treatment at lower concentrations (Supplementary Figure 5),
arguing against nonspeciﬁc effects, which could have re-
sulted from the relatively high radicicol concentration used
in Figure 4B and C, chosen to allow short incubation times.
Radicicol treatment did not affect cell macropinocytotic
activity, as assessed by ﬂuid-phase Lucifer Yellow uptake
(Supplementary Figure 6), and no toxic effects of radicicol
on KG-1 cells were observed, assessed both by cell recovery
and viability (data not shown). Taken together, these data
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Figure 3 KG-1 cytosol-mediated refolding in vitro is inhibited by radicicol. (A, B) Fireﬂy luciferase (A) or R. reniformis luciferase (B) were
chemically unfolded in 6M guanidine–HCl in ICT buffer (K). Refolding reactions were performed in ICT buffer alone (&) or in serial dilutions
of KG-1 cytosol in ICT buffer (m). (C) Chemically unfolded Fireﬂy luciferase was refolded in ICT buffer alone or in serial dilutions of KG-1
cytosol in ICT buffer with increasing radicicol concentrations (gray bars) or with DMSO as control (white bars). For all in vitro refolding
experiments, refolding efﬁciency was expressed as percentage of luciferase input in the refolding reaction. All graphs show the mean value
(7s.d.) of triplicate samples and they are representative of at least three independent experiments.
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exogenous luciferases internalized by KG-1 cells.
Primary human DCs can mediate refolding of Renilla
luciferase
The fragility of primary DCs prevented us from using SLO
permeabilization to evaluate cytosolic access by luciferase
in these cells; signiﬁcant ER and lysosomal leakage was
observed upon SLO treatment (data not shown). We therefore
used hypotonic lysis to release the total cellular contents
rather than SLO permeabilization to analyze luciferase refold-
ing in primary DCs. After 15-min incubation with inactive,
denatured Renilla luciferase, DCs were washed in ice-cold
PBS, resuspended in ice-cold 10mM Tris-chloride, pH 7.4, for
5min, and centrifuged at 2000g for 10min. Signiﬁcant luci-
ferase activity could be detected in the supernatants derived
from hypotonically lysed cells compared with those from an
equivalent number of non-lysed cells resuspended in PBS
(Figure 4D). The data suggest that Renilla luciferase is highly
likely to refold in the cytosol of primary human DCs.
Inhibitory shRNA for Hsp90 b signiﬁcantly decreases
cytosolic refolding
To further conﬁrm the role of Hsp90 in cytosolic refolding, we
attempted to independently ‘knock down’ the Hsp90 a and b
isoforms using small-hairpin RNA (shRNA) constructs. We
were unable to signiﬁcantly reduce expression of the Hsp90 a
isoform because KG-1 cells transduced with a speciﬁc shRNA
were impaired in their ability to grow, and we could not
recover enough cells to perform the experiment (data not
shown). Decreased growth of cells upon Hsp90 a knockdown
has been previously reported (Teng et al, 2004; Kunisawa and
Shastri, 2006). Hsp90 b, however, was more tractable. KG-1
cells were transduced with an shRNA construct speciﬁc for
the Hsp90 b isoform. A GFP-silencing sequence was used as
control. After selection in puromycin, we recovered two KG-1
cell clones (Hsp90 b.1 and Hsp90 b.2) with stable reduction
of Hsp90 b. Hsp90 a and b expression was quantitated by
SDS–PAGE followed by quantitative western blotting on
serially diluted cell extracts. Approximately 65% reduction
of Hsp90 b was obtained for both Hsp90 b.1 and Hsp90 b.2
clones compared with GFP–shRNA control cells (Figure 3A,
top panels). No signiﬁcant decrease in Hsp90 a protein was
observed (Figure 5A, middle panels); MHC class I heavy-
chain blots served as a loading control and normalizer
(Figure 5A, bottom panels).
To assess the effect of Hsp90 b reduction on refolding, the
shRNA-expressing cells were incubated for 15min with na-
tive or unfolded Renilla luciferase, followed by washing and
SLO permeabilization. Signiﬁcantly decreased cytosolic luci-
ferase activity was recovered from KG-1 cells with reduced
levels of Hsp90 b compared with GFP–shRNA control cells
(Figure 5B and C, black bars). No signiﬁcant luciferase
activity was detected in supernatants of non-permeabilized
cells (Figure 5B and C, white bars). No differences were
observed in the macropinocytotic activity of the Hsp90 b
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Figure 4 Refolding is required for the detection of cytosolic luciferase activity. (A) Native ( ) or chemically unfolded (K) R. reniformis
luciferase was added to KG-1 cells for the indicated times. Cells were then permeabilized with SLO in the presence of DTT (þ SLO, solid lines)
or resuspended in DPBS with DTT (  SLO, dashed lines) as a control. After centrifugation, supernatants from SLO-permeabilized cells or
control cells were analyzed for luciferase activity. The graph shows the mean value (7s.d.) of triplicate samples and it is representative of at
least three independent experiments. (B, C) KG-1 cells were pretreated at the indicated concentrations with radicicol or with DMSO as control
(grey columns) for 1h. After extensive washes in serum-free medium, Fireﬂy luciferase (B) or chemically unfolded R. reniformis luciferase in
PBS (C) were added for 15min to allow internalization. Cells were then permeabilized with SLO in the presence of DTT (þ SLO, grey columns)
or resuspended in DPBS with DTT (  SLO, white columns) as a control. After centrifugation, supernatants were analyzed for luciferase activity.
(D) Chemically unfolded R. reniformis luciferase was added for 15min to primary human DCs. Cells were then resuspended in PBS as control
(Ctr, grey column) or subjected to hypotonic lysis with 10mM Tris, pH 7.4 (black column). After centrifugation, supernatants were analyzed for
luciferase activity with a luminometer. All graphs show the mean value (7s.d.) of triplicate samples and they are representative of at least
three independent experiments.
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cells, as assessed by ﬂuid-phase Lucifer Yellow uptake
(Supplementary Figure 7). Together with the data showing
inhibition by radicicol, these experiments strongly support a
key role for the Hsp90 chaperone in the cytosolic refolding of
exogenous luciferases internalized by KG-1 cells.
Discussion
We previously showed that for cross-presentation in DCs,
exogenous antigens are translocated into the cytosol using
mechanisms related to ERAD (Ackerman et al, 2006). For part
of this work we puriﬁed phagosomes from KG-1 cells contain-
ing internalized Fireﬂy luciferase and showed that they could
transport the enzyme into the topological equivalent of the
cytosol. The translocation process was ATP-dependent and
required the active form of the AAA-ATPase, p97 (Ye et al,
2001; Ackerman et al, 2006). Perhaps the most surprising
aspect of this ﬁnding was that the translocated luciferase was
enzymatically active. In the present work we have extended
our previous ﬁndings to luciferases taken up by ﬂuid-phase
mechanisms. We showed that the appearance of active
enzyme in the cytosol could be inhibited by radicicol and
by reducing the levels of Hsp90 b. This indicates that cyto-
solic refolding is mediated by Hsp90, and implies that an
unfolding step occurs before translocation (see model in
Figure 6).
The SLO permeabilization approach provides a useful
strategy for determining the rate at which soluble proteins
internalized by the DC-like KG-1 cell line enter the cytosol.
Problems with cell fragility prevented us from using the same
technique with monocyte-derived DCs. However, hypotonic
lysis of DCs after internalization of inactive Renilla luciferase
released active enzyme, suggesting that DCs were similarly
capable of cytosolic refolding of internalized proteins
(Figure 4D). Previous work investigating cytosolic access of
exogenous proteins used imaging techniques such as immuno-
ﬂuorescence and electron microscopy, and focused on
single-cell analysis (Rodriguez et al, 1999; Houde et al,
2003). The SLO-permeabilization/luciferase release assay
allowed us to estimate retrotranslocation efﬁciency in
whole-cell populations over time, avoiding potential bias in
imaging selection. We were careful to exclude that lysosomal
or ER lumenal components were released by SLO (Figure 1C),
and we determined that SLO did not cause endosomal
permeabilization in KG-1 cells by using internalized
ﬂuorescein-conjugated dextran as an endocytic marker
(Supplementary Figure 1). Pores formed by SLO are 30-nm
diameter (Walev et al, 2001), large enough to accommodate a
dextran of 10kDa. Overall, these data conﬁrm that the
luciferase activity detected in supernatants from SLO-permea-
bilized cells is genuinely derived from the cytosol.
It is unclear from which structures retrotranslocation
into the cytosol occurs. Initial entry into the cells is likely
to involve macropinocytosis, an actin-dependent process
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Figure 5 Knockdown of Hsp90 b expression inhibits cytosolic refolding. (A) Serial dilutions of cell extracts from shRNAcontrol (Ctr) or shRNA
Hsp90 b (Hsp90 b.1 and Hsp90 b.2) KG-1 cells were subjected to SDS–PAGE and blotted for Hsp90 b (top panels) and a (middle panels)
isoform-speciﬁc antibodies. Membranes were also blotted for MHC I rat mAb as loading control (bottom panels). (B, C) Native (B) or
chemically unfolded (C) R. reniformis luciferase was added to shRNA control (Ctr) or shRNA Hsp90 b (Hsp90 b.1 and Hsp90 b.2) KG-1 cells for
15min. Cells were then washed and permeabilized with SLO in the presence of DTT (þ SLO, &) or resuspended in DPBS with DTT (  SLO, )
as a control. After centrifugation, supernatants from SLO-permeabilized cells or control cells were analyzed for luciferase activity with a
luminometer. Values are indicated as percent of those obtained with shRNA control cells. All graphs show the mean value (7s.d.) of triplicate
samples and they are representative of at least three independent experiments.
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ﬂuid. The ability of cytochalasin D to inhibit cytosolic luci-
ferase accumulation in KG-1 cells (Figure 2A; Supplementary
Figure 2), as well as the inability of the non-macropinocytotic
CEM cell line to mediate the process (Figure 1), are consistent
with this idea. After macropinocytosis, translocation into the
cytosol could occur from macropinosomes directly or it could
occur after exogenous protein entry into the ER. We have
provided some evidence based on immunoﬂuorescence ana-
lysis for the appearance of ER proteins in macropinosomes
(Ackerman et al, 2003), and also have shown that interna-
lized proteins can access the ER (Ackerman et al, 2005), so
both mechanisms seem possible. However, luciferase entry
into the cytosol of KG-1 cells was rapid, with enzymatic
activity detectable as early as 5min after initiation of inter-
nalization (Figures 1A, 2A, and 4A). The speed of the retro-
translocation and refolding suggests that recruitment of the
ER retrotranslocation machinery to macropinosomes is per-
haps more likely to be involved than transport of the enzyme
to the ER. Whether other cell types capable of macropinocy-
tosis, such as neutrophils or endothelial cells (Catizone et al,
1993; Botelho et al, 2002), can perform this function remains
to be investigated.
The identity of the retrotranslocation channel for ERAD is
still subject to debate (Tsai et al, 2002; Ahner and Brodsky,
2004; Meusser et al, 2005), and the same debate applies to the
work we describe here. There is evidence, particularly from
work with yeast, that the Sec61 channel is responsible
(Plemper and Wolf, 1999; Plemper et al, 1999), but evidence
from both yeast and mammalian cells suggests that the
multiple membrane-spanning protein Derlin-1 may be in-
volved (Lilley and Ploegh, 2004; Ye et al, 2004; Wahlman
et al, 2007). ExoA has been reported to block the Sec61
channel and inhibit the retrotranslocation of peptides from
ER vesicles (Koopmann et al, 2000), and here we have shown
that it inhibits the cytosolic recovery of luciferase (Figure 2B),
but it is conceivable that other channels could be implicated
in this process. However, regardless of the channel involved,
the luciferase we ﬁnd in the cytosol is active and therefore
presumably intact; thus, the channel must be capable of
translocating a protein of at least 62kDa. This is the Mr for
Fireﬂy luciferase, which is folded into two compact domains
(Conti et al, 1996). The data showing that both radicicol and
Hsp90 b knockdown inhibit refolding, and the observation
that denatured Renilla luciferase can be reactivated after
internalization, argue that unfolding is a pre-requisite for
translocation and that Hsp90 then mediates cytosolic refold-
ing. Thus, the diameter of the retrotranslocation channel
need not be unusually large. However, glycans remain
attached during retrotranslocation for ERAD (Wiertz et al,
1996a,b), and there are data arguing that folded domains,
including EGFP (25kDa) (Fiebiger et al, 2002) and a folded
dihydrofolate reductase domain (42kDa) (Tirosh et al, 2003),
can be retrotranslocated. There is no reason to suppose that
Exogenous protein
p97 AAAATPase
Retrotranslocon
MHC I loading complex
Hsp90
Proteosome
Unfolded protein
Refolding Degradation
Figure 6 Model for ERAD retrotranslocation and Hsp90-mediated cytosolic refolding in DCs. In DCs exogenous proteins are efﬁciently
internalized and retrotranslocated from the endosomal compartment or from the ER into the cytosol. At least partial unfolding of the exogenous
protein may be required for efﬁcient retrotranslocation to occur. Once in the cytosol, the internalized protein can be degraded by the
proteasome to generate immunogenic peptides, or it can regain its activity by Hsp90 chaperone-mediated refolding.
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presentation. However, denatured Renilla luciferase appears
in the cytosol more rapidly than the native form (Figure 4A),
indicating that prior in vitro unfolding may signiﬁcantly
speed up the retrotranslocation process. Perhaps certain
checkpoints involved in substrate detection, recognition,
and unfolding are bypassed, allowing faster retrotranslo-
cation to occur. However, the validity of this conclusion
is tempered by the requirement for higher concentrations
of the unfolded luciferase to achieve a usable signal.
Conceivably this could be responsible for the more rapid
appearance of the non-native form in the cytosol.
At least two ERAD pathways exist: the ERAD-L and the
ERAD-C pathway (Vashist and Ng, 2004; Carvalho et al,
2006). During protein synthesis, the ERAD-C pathway moni-
tors the folding status of cytosolic domains of membrane
proteins and rapidly clears misfolded variants from the ER.
This occurs without regard to the state of the lumenal
domain. If the conformation of the cytosolic domain passes
the ERAD-C checkpoint, the ERAD-L pathway monitors the
state of the lumenal domain. If a lesion is detected, the
protein is processed for ERAD using a distinct set of factors
not required for the ERAD-C pathway. In DCs, exogenous
proteins can be directly delivered to the ER lumen for retro-
translocation or can be retrotranslocated from ER-containing
phagosomes through the ERAD pathway. In both cases, we
might speculate that extracellular proteins delivered to ER
lumenal compartments would preferentially use ERAD-L.
Previous work in yeast showed the importance of Hsp90 in
maintaining the stability of the ERAD-L substrate CFTR
(Youker et al, 2004). This would be in agreement with the
key role of Hsp90 indicated by our luciferase cytosolic
refolding data.
Fireﬂy luciferase readily refolds in vitro in the presence of
puriﬁed Hsp90, Hsp70, and the PA28 ATPase proteasomal
subunit (Minami et al, 2000, 2001). The use of radicicol as an
inhibitor provides evidence for Hsp90 as the key cytosolic
chaperone that mediates refolding after retrotranslocation.
Radicicol did not affect the efﬁciency of luciferase internali-
zation, indicating that decreased enzymatic activity in
the cytosol was speciﬁcally due to Hsp90 inhibition
(Supplementary Figure 6). The effect of radicicol is also
unlikely to be mediated by the ER Hsp90 homologue
GRP94, because even lower concentrations than those
used in the primary experiments gave similar results
(Supplementary Figure 5). It has been reported that the
radicicol afﬁnity for Hsp90 is ﬁvefold higher than its afﬁnity
for GRP94 (Schulte et al, 1999). This argues against the
possibility that the decreased cytosolic luciferase activity
seen upon radicicol treatment is due to decreased retrotran-
slocation caused by GRP94 inhibition.
Unfortunately, we were unable to ‘knock down’ both the
Hsp90 a and b isoforms using either siRNA oligonucleotides
or shRNA approaches in the KG-1 cell line. Our attempts to
obtain signiﬁcant and stable silencing for Hsp90 a in KG-1
cells were unsuccessful. The reduced rate of cell division
previously reported (Teng et al, 2004; Kunisawa and Shastri,
2006) combined with the high number of cells required
for our experiments rendered the Hsp90 a shRNA strategy
unusable. We were able to establish B65% stable knock
down for the Hsp90 b isoform in KG-1 cells (Figure 5A). We
observed no differences in Lucifer Yellow uptake between
shRNA control and shRNA Hsp90 b cells (Supplementary
Figure 7), and no effect on cell growth rate or survival was
observed (data not shown). Reduced levels of Hsp90 b caused
a signiﬁcant decrease in enzymatic activities recovered in the
cytosolic fraction using native or unfolded Renilla luciferase
as exogenous protein substrates (Figure 5B and C), conﬁrm-
ing the role of Hsp90 suggested by the potent inhibitor
radicicol (Figure 4).
Workers using OVA as a probe for cytosolic access in DCs
found only a 30-kDa fragment of the protein in the cytosol,
indicating that proteolysis had occurred, but there is no
evidence that proteolysis is required for cytosolic access
(Rodriguez et al, 1999). The reduced yield of active Renilla
luciferase when denatured enzyme was internalized, com-
pared with the activity recovered when native enzyme was
used, might indicate that proteolysis is more likely when the
retrotranslocated substrate is totally denatured. No signiﬁ-
cant differences in the luciferase activity recovered were
observed in cells pretreated with concanamycin B or leupep-
tin to inhibit lysosomal proteolysis (data not shown).
However, proteolysis of acquired proteins could still occur
in endocytic vesicles as well as in the cytosol after transloca-
tion. Lactacystin pretreatment of KG-1 cells followed by SLO
treatment caused some ER lumenal contamination of the
released cytosol, as assessed by western blotting for GRP94
(data not shown), so we were unable to determine if protea-
some inhibition resulted in an increase in cytosolic luciferase
activity. However, upon prolonged incubation, cytosolic luci-
ferase activity did decrease (Figure 4A), which suggests that
the refolded enzyme is ultimately degraded by cytosolic
proteolysis.
An estimate of retrotranslocation efﬁciency can be extra-
polated by comparing the luciferase activity recovered
in SLO-permeabilized samples (Figure 1A) to the total
amount of internalized enzyme measured by cell lysis
(Supplementary Figure 2). Thirty minutes after internaliza-
tion was initiated, at least 60% of the internal luciferase could
be recovered in the cytosol, suggesting that the level of
proteolysis, either pre- or post-retrotranslocation, is relatively
low for luciferase. For other internalized proteins, degrada-
tion may well be the predominant fate. This is the fate that
gives rise to the peptides that are transported into the ER by
TAP, and therefore the key pathway involved in cross-pre-
sentation. However, the unfolding/refolding mechanism we
have identiﬁed that allows exogenous proteins to regain their
activity in the cytosol could potentially be exploited by DCs
for some aspects of their regulation or function.
There are a few examples in the literature where cytosolic
delivery of growth factors and signaling molecules can med-
iate biological effects. Fibroblast growth factor (FGF)-1 and
FGF-2 are internalized through the FGF receptor and then
dislocated into the cytosol. Subsequently FGF trafﬁcs to the
nucleus and binds to speciﬁc DNA sequences, causing
distinct cellular effects; cytosolic FGF triggers a signaling
cascade temporally and physiologically different from stimu-
lation via FGF receptor tyrosine kinase (Wesche et al, 2005,
2006). A similar phenomenon has also been reported for
epidermal growth factor (EGF). EGF binding to the cell-sur-
face EGF receptor (EGFR) triggers EGF–EGFR trafﬁcking to
the ER. EGF is then retrotranslocated into the cytosol, appar-
ently through Sec61, signaling to the nucleus and inducing
cyclin D gene expression (Lin et al, 2001; Liao and Carpenter,
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apply to exogenous molecules internalized by DCs. For
example, proteins secreted by neighboring cells or contained
in apoptotic bodies could be internalized by DCs, penetrate
the cytosol, and modulate their ability to migrate or function
as APCs. To date, however, there are no data supporting this
notion.
Materials and methods
Antibodies and reagents
Rat anti-GRP94mAb and rabbit anti-MAPK pAb were from Stressgen
Biotechnologies and Cell Signaling, respectively. QuantiLum
recombinant Fireﬂy luciferase (14.9mg/ml) and luciferin were
purchased from Promega. R. reniformis and native coloenterazine
(nCTZ) were purchased from Prolume, AZ. R. reniformis luciferase
was resuspended in PBS; nCTZ (1mg/ml stock in ethanol) was
diluted 1:1000 in PBS for luciferase assays. SLO was from Aalto,
Ireland. Cytochalasin D and radicicol were from Sigma and AG
Scientiﬁc Inc., CA, respectively. ExoA was from EMD.
Cells and cultures
The human DC-like KG1 and human T lymphoblastoid cell line
CEM were previously described (Howell et al, 1985; Ackerman and
Cresswell, 2003). Primary human DCs were generated (Sallusto and
Lanzavecchia, 1994) from human mononuclear cells isolated using
lymphocyte separation medium (LSM; Cellgro) according to the
manufacturer’s protocol.
SLO cell permeabilization
A total of 6 10
6 KG-1 or CEM cells in 1% FBS IMDM were
incubated with soluble recombinant Fireﬂy or R. reniformis
luciferases for the indicated time points at the ﬁnal concentrations
of 49 and 0.13mg/ml, respectively. After extensive washes in serum-
free medium, cells were permeabilized with SLO as previously
described (Androlewicz et al, 1993). Brieﬂy, cells were resuspended
in 200ml serum-free medium and incubated for 15min on ice in the
presence of 0.3mM DTT with or without SLO at 22mg/ml. Cells
were then washed three times with Dulbecco’s phosphate-buffered
saline without calcium and magnesium (DPBS; Gibco) and
resuspended in 100ml DPBS. Cells were then incubated at 371C
for 5min to allow permeabilization. After centrifuging at 14000g
for 5min at 41C, 20ml of supernatants from SLO-permeabilized cells
were analyzed for luciferase activity with 100ml of either nCTZ or
luciferin (Promega) using a luminometer (GE).
Fireﬂy and R. reniformis luciferase chemical unfolding and
in vitro refolding
In vitro refolding assays were performed as previously described
(Minami et al, 2000). Brieﬂy, chemical unfolding was performed in
6M guanidine–HCl in ICT buffer (50mM HEPES, 78mM KCl, 4mM
MgCl2, 8.37mM CaCl2, and 10mM EGTA) for 30min at room
temperature. Refolding reactions were performed for 30min at room
temperature with serial dilutions of KG-1 cytosol, isolated as
previously described (Ackerman et al, 2006), in ICT buffer in the
presence or absence of radicicol. Refolding efﬁciency was calculated
as regained luciferase activity, measured by luminometer, and
expressed as percentage of luciferase input in the refolding reaction.
Unfolded R. reniformis luciferase refolding in KG-1 cells and
in primary human DCs
R. reniformis luciferase was chemically unfolded in 6M guanidine–
HCl in ICT buffer for 2h and then dialyzed overnight against PBS,
retaining its unfolded form. For experiments with KG-1 cells, 0.3mg
of native or 40mg of chemically unfolded R. reniformis luciferases
were added to KG-1 cells at the ﬁnal concentration of 0.13 or 20mg/
ml, respectively. Cells were then washed three times with DPBS and
resuspended in 100ml DPBS before permeabilization with SLO as
described above. After centrifuging at 14000g for 5min at 41C, 20ml
of supernatants from SLO-permeabilized cells were analyzed for
luciferase activity. For experiments with human DCs, 30mgo f
chemically unfolded R. reniformis luciferase in PBS were added to
2 10
6 primary human DCs seeded in Ultra Low Cluster Plates
(Costar). After 15-min incubation at 371C to allow internalization,
DCs were washed with cold PBS and resuspended in 100ml of PBS
or subjected to hypotonic lysis with 100ml of 10mM Tris, pH 7.4,
both in the presence of protease inhibitors (EDTA-free; Roche). After
centrifuging at 2000g for 10min at 41C, 20ml of supernatants were
analyzed for luciferase activity.
Western blotting
Supernatants from SLO-permeabilized cells or total cell lysates were
separated by reducing SDS–PAGE (10% (w/v) acrylamide) and
electrophoretically transferred to Immobilon-P membrane (Milli-
pore). The membrane was blocked in TBS with 0.05% Tween 20
with 5% dehydrated milk and probed with rabbit anti-human GILT
serum (1/10000), rat anti-GRP94mAb, or anti MAPK rabbit Ab.
Membranes were then washed, incubated with HRP-conjugated
goat anti-rabbit or anti-rat IgG (1/5000; Jackson ImmunoResearch
Laboratories) and ECL substrate (SuperSignal West Pico; Pierce),
and exposed to ﬁlm.
Hsp90 b shRNA in KG-1 cells
shRNA-expressing cells were generated as previously described
(Barton and Medzhitov, 2002) using the pSUPER.retro. puro vector
(OligoEngine). The siRNA sequence speciﬁc for the Hsp90
b isoform has been previously described (Kunisawa and Shastri,
2006); the shRNA construct targeting GFP used as control was a
kind gift from Dr Hidde Ploegh (Lilley and Ploegh, 2005). Clonal
selection was performed in 20mg/ml puromycin. Control and Hsp90
b shRNA KG-1 cells were maintained in 20mg/ml puromycin to
maintain selection pressure. Knockdown was assessed by reducing
SDS–PAGE followed by western blotting with Hsp90 b isoform-
speciﬁc rabbit Ab (1/1000; Lab Vision Corporation). To ensure
speciﬁcity, membranes were stripped for 4min in 0.2M NaOH and
reprobed with Hsp90 a isoform-speciﬁc rabbit Ab (1/2000;
Stressgen). Membranes were also probed with anti-MHC-I rat
mAb 3B10.7 as a loading control and normalizer. Alkaline
phosphatase-conjugated goat anti-rabbit or anti-rat IgG (1/5000;
Jackson ImmunoResearch Laboratories) and ECF substrate (GE)
were used for signal detection with a FluorImager (GE).
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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